Boards should ask what is proven, what is assumed, what customer need is urgent, what manufacturing risk remains, and what milestone will actually reduce uncertainty.
TIGRE answer page
Boards should ask what is proven, what is assumed, what customer need is urgent, what manufacturing risk remains, and what milestone will actually reduce uncertainty.
The point is not to admire technical novelty. The point is to decide whether the technology changes a customer, manufacturing, funding, acquisition, or board decision.
TIGRE separates what is proven from what is assumed, then maps the implications for product focus, customer adoption, capital milestones, manufacturing readiness, and decision risk.
For investors, acquirers, boards, and advisory partners.
For founders and technical teams trying to sharpen the business logic.
Short failure-mode screens for hard-tech decisions.